David Lebwohl, EVP, Chief Medical Officer at Intellia Therapeutics, Inc. (NTLA), sold 3,400 shares at $132.62 ($452K) on 2021-11-05, disclosed to the SEC on 2021-11-09.
Open-market sale of $452k NTLA by EVP, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $131.71 | 1,200 | $158K | 35.0% |
| 2 | $132.62 | 452 | $60K | 13.3% |
| 3 | $132.62 | 452 | $60K | 13.3% |
| 4 | $134.07 | 548 | $73K | 16.3% |
| 5 | $134.07 | 548 | $73K | 16.3% |
| 6 | $135.34 | 200 |
| $27K |
| 6.0% |
| Total | $132.93 avg | 3,400 | $452K | 100% |
| Filing → |
| NTLA | SELL | 2024-01-05 | $344K | — | Filing → |
| NTLA | SELL | 2023-01-06 | $192K | — | Filing → |
| NTLA | SELL | 2022-03-03 | $236K | — | Filing → |